CD8A and neoplasm: Given that TIA-1 is hypothesized as a marker for activated CD8+ T-cells, we verified the coexpression of TIA-1 on CD8+ T cells by flow cytometry on tumor infiltrating lymphocytes (TILs) from 10 freshly excised clinical specimens.